logo
logo

Love Pharma Inc. Announces Second Closing Of Financing

Jun 29, 2022•about 3 years ago
Vancouver

Description

VANCOUVER, BC / June 29, 2022 / LOVE Pharma Inc. ("LOVE" and or "the Company") (CSE:LUV)(FSE:G1Q0), announces it has completed a second closing of its previously announced non-brokered private placement. The Company accepted subscriptions for 50,735,771 units at a price of $0.011 per unit, for gross proceeds of $558,093.50. Each unit consists of one common share and one common share purchase warrant

Company Information

Company

Love Pharma

Location

Vancouver, Washington, United States

About

With a focus on the global sexual Health and Wellness markets, Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) was founded in 2020, with a mission to bring to market innovative products that enhance sexual health and wellness while providing an improved quality of life. Love Pharma holds exclusive licenses to produce market, package, sell, and distribute patent-protected therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America.